Amid Safety Warnings, 37% of Voters Oppose Hydroxychloroquine for COVID-19
29% of all voters support the use of the drug for coronavirus patients; 34% didn’t know or had no opinion.
52% of Republicans support the drug’s use for COVID-19, compared to 13% of Democrats who said the same.
An earlier poll found 46% of voters supported the use of the drug “before the National Institutes of Health is done researching its effectiveness.”
Debate over the use of hydroxychloroquine as a potential COVID-19 treatment has intensified over the past few weeks since President Donald Trump first touted the anti-malarial drug.
Morning Consult polling conducted earlier this month showed almost half of voters supported the use of hydroxychloroquine for treating the coronavirus as a national health agency launched a study on the drug. But as the Trump administration’s health agencies now warn against personal use of hydroxychloroquine, new survey data indicates voter support for it is murky.
The Morning Consult/Politico poll, which was conducted April 24-26 among 1,991 registered voters, showed a plurality of respondents (37 percent) are opposed to the use of hydroxychloroquine to treat COVID-19 based on what they’ve seen, read or heard, while 29 percent said they do support it and 34 percent said they don’t know or have no opinion.
A majority of Democrats (56 percent) oppose the drug’s use as a coronavirus treatment, while 13 percent expressed support. Just over half of Republicans (52 percent) said they support the use of hydroxychloroquine for COVID-19, with 14 percent saying the opposite. The poll has a margin of error of 2 percentage points.
The new survey was conducted as the Food and Drug Administration issued a warning Friday that advised people against taking hydroxychloroquine or chloroquine as a treatment for the coronavirus outside of a hospital setting or a clinical trial. In its guidance, the FDA said the drugs “have not been shown to be safe and effective for treating or preventing COVID-19” and mentioned reports of “serious heart rhythm problems” in coronavirus patients who have taken the drugs, including in combination with the antibiotic azithromycin.
The National Institutes of Health issued similar guidance on April 21 as it continues to conduct its own clinical trial on the drug, which it began on April 9. Twenty percent of voters said they heard “a lot” about NIH’s guidance on hydroxychloroquine and azithromycin to treat COVID-19, including 30 percent of Democrats and equal shares of independents and Republicans (14 percent).
Morning Consult first asked voters about support for hydroxychloroquine in a survey conducted April 10-12 after the launch of the NIH study. At that time, when asked if they supported or opposed the use of the drug for COVID-19 “before the National Institutes of Health is done researching its effectiveness,” nearly half of voters (46 percent) supported it, compared to 33 percent who opposed and 21 percent who did not know or had no opinion.
Republicans were most likely to support hydroxychloroquine for treatment before the conclusion of the NIH study at 71 percent compared to 12 percent who opposed, Nearly 3 in 10 Democrats supported the drug’s use for COVID-19 at the time, compared to half who opposed it.
Brian Yermal is a research editor on the Industry Intelligence team, where he edits the team’s email newsletters, written analysis and reports. Brian previously worked as a copy editor at the Altoona Mirror newspaper in central Pennsylvania. He graduated from Penn State University with a bachelor’s degree in journalism.